Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2037

Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.

Patents
1,615

Quick answer

1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9732333

    Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

    Protalix Ltd. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9732311

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuteria Beverages, LLC · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9732161

    Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9732114

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9732110

    Nucleoside and nucleotide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9732124

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9732189

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9732073

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9732070

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9732080

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9732062

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9730894

    Stabilized HME composition with small drug particles

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9730897

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9730911

    Cannabis extracts and methods of preparing and using same

    United Cannabis Corp. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9730915

    Method for preventing or treating diseases associated with a reduced density of interferon receptors

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9730930

    Treatment for vitiligo

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9730965

    Perivascular stem cell composition for bone

    The Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9730966

    Method of reducing appetite in a human subject comprising administering krill oil composition

    AKER BIOMARINE ANTARCTIC AS · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9730978

    Compositions for treating dry eye disease

    Thc Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9732095

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9731037

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Universitair Medisch Centrum Utrecht · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9730962

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9730954

    miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9730910

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9730972

    Skin tightening lotion

    Ashley Diana Black International Holdings, LLC · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9730989

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9731008

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9731009

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9731023

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9731002

    HIV-1 GP 120 V1/V2 antigens and immunological uses thereof

    The Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9731011

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9730892

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 2017231981

    COMPOSITIONS OF MULTIPLE ARIPIPRAZOLE PRODRUGS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu Aug 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9737520

    Aclidinium for use in improving the quality of sleep in respiratory patients

    Almirall, S.A. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9737533

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9737560

    Process for preparation of a humic substance based gel for targeted external application

    BlackBalm, LLC · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9737571

    Compositions of aquatic origin for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9737546

    Small molecules to enhance P53 activity

    The Regents of the University of California · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9738669

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Galera Labs, LLC · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9738670

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Galera Labs, LLC · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9738703

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9737483

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9738724

    Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9738678

    Substituted nucleoside derivatives with antiviral and antimicrobial properties

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9737691

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9737554

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9737564

    Citrate containing beverage

    The Regents of the University of California · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9737600

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2037?

1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.